COVID-19 Vaccination: What Challenges Are We Going to Face

Main Article Content

Sara Zibadi
Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; USERN Office, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Noosha Samieefar
Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; USERN Office, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Fatemeh Sodeifian
Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; USERN Office, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Narjes Mosavari
USERN Office, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Nima Rezaei
Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Keywords

COVID-19, SARS-CoV-2, Vaccine, Vaccination

Abstract

NA

Downloads

Download data is not yet available.
Abstract 444 | PDF Downloads 293

References

Samieefar, N., et al., Country Quarantine During COVID-19: Critical or Not? Disaster Med Public Health Prep, 2020: p. 1-2.
2. Rawat, K., P. Kumari, and L. Saha, COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. European journal of pharmacology, 2020: p. 173751.
3. WHO. COVID-19 Vaccines. [cited 2021 May 6]; . Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.
4. WHO. Coronavirus disease (COVID-19): Vaccines. [cited 2021 May 6]. Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines.
5. WHO. Draft landscape tracker of COVID-19 candidate vaccines. [cited 2021 May 6]. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
6. CDC. Different COVID-19 Vaccines. [cited 2021 May 6]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html.
7. CDC. Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in
the United States. [cited 2021 May 6]. Available from: https://www.cdc.gov/vaccines/covid19/info-by-product/clinical-considerations.html.
8. CDC. COVID-19 Vaccinations in United States. [cited 2021 May 6]. Available from: https://covid.cdc.gov/covid-data-tracker/#vaccinations.
9. So, A.D. and J. Woo, Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. bmj, 2020. 371.
10. Adhanom Ghebreyesus, T.J. [cited 2021 May 6]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-148th-session-of-the-executive-board.
11. Calina, D., et al., Towards effective COVID‑19 vaccines: Updates, perspectives and challenges. International journal of molecular medicine, 2020. 46(1): p. 3-16.
12. de Gomensoro, E., G. Del Giudice, and T.M. Doherty, Challenges in adult vaccination. Annals of medicine, 2018. 50(3): p. 181-192.
13. Chung, J.Y., M.N. Thone, and Y.J. Kwon, COVID-19 vaccines: The status and perspectives in delivery points of view. Advanced drug delivery reviews, 2020.
14. Badgujar, K.C., V.C. Badgujar, and S.B. Badgujar, Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020. 14(5): p. 1361-1376.

Article Sidebar

PDF
Published
Sep 2, 2021
DOI https://doi.org/10.23750/abm.v92i4.11759

Article Details

How to Cite

1.
Zibadi S, Samieefar N, Sodeifian F, Mosavari N, Rezaei N. COVID-19 Vaccination: What Challenges Are We Going to Face. Acta Biomed [Internet]. 2021 Sep. 2 [cited 2023 Sep. 26];92(4):e2021379. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/11759
Issue
Vol. 92 No. 4 (2021)
Section
CORRESPONDENCE - SPECIAL COVID19

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)

1 2 > >>